Skip to content

Necessity of internal limiting membrane peeling in treatment of epiretinal membrane

Necessity of internal limiting membrane peeling in treatment of epiretinal membrane - Necessity of internal limiting membrane peeling in treatment of epiretinal membrane

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035094
Enrollment
60
Registered
2018-12-01
Start date
2014-12-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic epiretinal membrane

Interventions

with internal limiting membrane peeling in surgery for epiretinal membrane without internal limiting membrane peeling in surgery for epiretinal membrane

Sponsors

Department of Ophthalmology, Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with idiopathic epiretinal membrane 2. Patients who have subjective symptoms and objective findings of dysphagia or decreased vision. 3. Patients who aged 20 years or older and under 90 years old at the time of consent acquisition 4. After receiving sufficient explanation for participation in this study, patients who obtained document consent by the patient's free will with sufficient understanding

Exclusion criteria

Exclusion criteria: Patients applicable to even one of the following are excluded as subjects. 1. Patients with secondary epiretinal membrane (traumatic, retinal hiatus, retinal vascular lesions etc). 2. A patient forming a pseudo macular hole. 3. Patients who have complicated other eye diseases affecting visual field narrowing such as glaucoma. 4. Patients who are cloudy with cornea and intermediate translucency. 5. Patient with a history of vitrectomy 6. Patients with myopia with an axial axis of 25.00 mm or more or 6.00 D or more. 7. In addition, patients whose research managers judged inappropriate as subjects

Design outcomes

Primary

MeasureTime frame
Retinal sensitivity at preoperative and postoperative 1 month, 3 months, 6 months

Secondary

MeasureTime frame
Visual acuity and central macular thickness at preoperative and postoperative 1, 3 3, 6 months

Countries

Japan

Contacts

Public ContactRyota Kono

Graduate School of Biomedical Sciences, Nagasaki University Department of Ophthalmology and Visual Sciences

kounoryouta818@nagasaki-u.ac.jp0958197345

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026